What's in the Offing for Ventas Stock This Earnings Season?
Werte in diesem Artikel
Ventas, Inc. VTR is scheduled to report second-quarter 2025 results on July 30, after market close. The quarterly results are likely to display year-over-year growth in revenues and normalized funds from operations (FFO) per share.In the last reported quarter, this Chicago-based healthcare real estate investment trust (REIT) delivered a normalized FFO per share of 84 cents, beating the Zacks Consensus Estimate of 82 cents. The quarterly results reflected an increase in same-store cash net operating income, led by higher investments and improved same-store average occupancy in the SHOP segment.Ventas’ normalized FFO per share surpassed the Zacks Consensus Estimate in three of the trailing four quarters and met in the remaining period, with the average beat being 1.24%. The graph below depicts this surprise history: Ventas, Inc. Price and EPS Surprise Ventas, Inc. price-eps-surprise | Ventas, Inc. Quote Factors at PlayIn the second quarter, Ventas’ senior housing operating portfolio (SHOP) is likely to have benefited from an aging U.S. population and a rise in healthcare expenditure by this age cohort, which is generally higher than the average population. With the segment witnessing positive net move-ins, occupancy is expected to have remained high.A well-diversified tenant base with long-term leases is expected to have contributed well to stable rental revenue generation, boosting the top line.However, the triple-net leased properties are likely to be affected during the to-be-reported quarter. Further, high interest expenses are expected to have cast a pall on the company’s performance to some extent.VTR’s Q2 ProjectionsThe Zacks Consensus Estimate for second-quarter resident fees and services is pegged at $977.1 million, suggesting an increase from $817.6 million reported in the year-ago period.The Zacks Consensus Estimate for second-quarter revenues is currently pegged at $1.37 billion, implying a 14.3% increase from the prior-year quarter’s reported figure.The consensus mark for outpatient medical and research portfolio rental income for the second quarter is pegged at $222.6 million, indicating an increase from $218.9 million reported in the year-ago period.However, the Zacks Consensus Estimate for second-quarter triple-net leased properties' rental income is pegged at $153.5 million, suggesting a marginal decrease from the $153.9 million reported in the year-ago period.Ventas’ activities during the soon-to-be-reported quarter were inadequate to gain analysts’ confidence. The Zacks Consensus Estimate for second-quarter FFO per share has remained unchanged at 85 cents over the past two months. However, the figure implies an increase of 6.3% from the year-ago quarter’s reported number.What Our Quantitative Model PredictsOur proven model does not conclusively predict a surprise in terms of FFO per share for Ventas this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an FFO beat, which is not the case here.Ventas currently has an Earnings ESP of -1.10% and carries a Zacks Rank of 3. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.Stocks That Warrant a LookHere are two stocks from the broader REIT sector — VICI Properties VICI and SBA Communications SBAC — that you may want to consider, as our model shows that these have the right combination of elements to report a surprise this quarter.VICI, scheduled to report quarterly numbers on July 30, has an Earnings ESP of +15.43% and carries a Zacks Rank of 3.SBA Communications is slated to report quarterly numbers on Aug. 4. SBAC has an Earnings ESP of +1.86% and carries a Zacks Rank of 3 presently. You can see the complete list of today’s Zacks #1 Rank stocks here.Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.#1 Semiconductor Stock to Buy (Not NVDA)The incredible demand for data is fueling the market's next digital gold rush. As data centers continue to be built and constantly upgraded, the companies that provide the hardware for these behemoths will become the NVIDIAs of tomorrow.One under-the-radar chipmaker is uniquely positioned to take advantage of the next growth stage of this market. It specializes in semiconductor products that titans like NVIDIA don't build. It's just beginning to enter the spotlight, which is exactly where you want to be.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ventas, Inc. (VTR): Free Stock Analysis Report SBA Communications Corporation (SBAC): Free Stock Analysis Report VICI Properties Inc. (VICI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Ventas und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Ventas
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Ventas
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Ventas Inc.
Analysen zu Ventas Inc.
Datum | Rating | Analyst | |
---|---|---|---|
03.09.2019 | Ventas Equal Weight | Barclays Capital | |
04.05.2018 | Ventas Market Perform | BMO Capital Markets | |
22.03.2017 | Ventas Hold | SunTrust | |
21.11.2016 | Ventas Neutral | Mizuho | |
13.07.2016 | Ventas Hold | Argus Research Company |
Datum | Rating | Analyst | |
---|---|---|---|
04.05.2018 | Ventas Market Perform | BMO Capital Markets | |
06.07.2016 | Ventas Buy | Mizuho | |
05.04.2016 | Ventas Buy | Mizuho | |
03.03.2016 | Ventas Buy | Mizuho | |
15.01.2016 | Ventas Market Perform | BMO Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
03.09.2019 | Ventas Equal Weight | Barclays Capital | |
22.03.2017 | Ventas Hold | SunTrust | |
21.11.2016 | Ventas Neutral | Mizuho | |
13.07.2016 | Ventas Hold | Argus Research Company | |
02.05.2016 | Ventas Equal Weight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
24.05.2010 | Ventas "underperform" | Robert W. Baird & Co. Incorporated |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Ventas Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen